Diabetic Neuropathic Pain Guildeline Updates - What's New?

The American Academy of Neurology recently updated guidelines for the treatment of Diabetic Neuropathic Pain (DNP), which is a common condition for individuals with diabetes. Treatment is often non-evidence based and creating a care plan may be difficult. Dr. John Swegle, a pain management expert, joins host Geoff Wall to discuss the updates on Diabetic Neuropathic Pain treatment recommendations and the evidence we have. 

Guest: 

John Swegle, PharmD, BCPS, BCACP

Clinical Associate Professor

University of Iowa College of Pharmacy

Redeem your CPE or CME credit here!

Need a membership?

References and resources: 

Price R, Smith D, Franklin G, et al. Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee. Neurology. 2022 Jan 4;98(1):31-43. doi: 10.1212/WNL.0000000000013038. PMID: 34965987.

Learning Objectives: 

1. Select an appropriate first line medication for diabetic neuropathic pain (DNP) based on the 2022 guidelines

2. Describe the treatment effects of the drugs used for DNP in the 2022 guidelines

Dr. Wall is a member of the Janssen Speaker's Bureau. 

Dr. John Swegle reports no actual or potential conflicts of interest associated with this episode.

Continuing Education Information:

0.05 CEU | 0.5 Hrs

ACPE UAN: 0107-0000-22-057-H01-P

Initial release date: 01/03/22

Expiration date: 01/03/2023

Additional CPE & CME details can be found here.